Improving Brain Tumour Care surveys share your experiences and help create change

Compassionate use

A treatment option that allows doctors in the European Union (EU) to prescribe to patients, a promising medicine which has not yet been authorised (licensed) for their condition. It can only be used, if there are no other satisfactory authorised therapies, and the patient cannot enter a clinical trial. Each country has their own rules about how this can be used. In the UK this is known as the Early Access to Medicines Scheme (EAMS)